All About Erbitux Cyramza Metastatic Colorectal Cancer Treatment
In America, it is estimated that 1 in every 21 men and 1 in every 23 women will develop colorectal cancer in their life. It accounts for about 8% of all cancers and it is the second deadliest cancer in women and the third in men.
Colorectal cancer refers to any cancer that originates from the colon or the rectum, or precisely from the large intestines. It normally starts as polyps or growth on the inner lining of the intestines. These growths can either be benign, meaning non-cancerous, or malignant, thus cancerous. If they are malignant, they are able to metastasis or spread to other organs.
Erbitux cyramza metastatic colorectal cancer treatment is a combination of drugs used for patients whose cancer has spread to other organs.